These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17218666)

  • 21. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
    Wu Z; Liu D; Sui Y
    J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of multiple readouts into the z' factor for assay quality assessment.
    Kümmel A; Gubler H; Gehin P; Beibel M; Gabriel D; Parker CN
    J Biomol Screen; 2010 Jan; 15(1):95-101. PubMed ID: 19940084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistics and decision making in high-throughput screening.
    Coma I; Herranz J; Martin J
    Methods Mol Biol; 2009; 565():69-106. PubMed ID: 19551358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chemogenomic approach to discovering target-selective drugs.
    Janzen WP; Hodge CN
    Chem Biol Drug Des; 2006 Jan; 67(1):85-6. PubMed ID: 16492154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a human tumor colony-forming assay to new drug screening.
    Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
    Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS; Player MR
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
    Huber W
    J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays.
    Zhang XD
    J Biomol Screen; 2007 Aug; 12(5):645-55. PubMed ID: 17517904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating real-life high-throughput screening data.
    Gribbon P; Lyons R; Laflin P; Bradley J; Chambers C; Williams BS; Keighley W; Sewing A
    J Biomol Screen; 2005 Mar; 10(2):99-107. PubMed ID: 15799953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A generally applicable, high-throughput screening-compatible assay to identify, evaluate, and optimize antimicrobial agents for drug therapy.
    Kleymann G; Werling HO
    J Biomol Screen; 2004 Oct; 9(7):578-87. PubMed ID: 15475477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
    Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
    J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges of high throughput screening against cell surface receptors.
    Major JS
    J Recept Signal Transduct Res; 1995; 15(1-4):595-607. PubMed ID: 8903966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.
    Perrin D; Frémaux C; Scheer A
    J Biomol Screen; 2006 Jun; 11(4):359-68. PubMed ID: 16751332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.
    Di L; Kerns EH; Hong Y; Kleintop TA; McConnell OJ; Huryn DM
    J Biomol Screen; 2003 Aug; 8(4):453-62. PubMed ID: 14567798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical and graphical methods for quality control determination of high-throughput screening data.
    Gunter B; Brideau C; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):624-33. PubMed ID: 14711388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enabling high-throughput discovery.
    Vaschetto M; Weissbrod T; Bodle D; Güner O
    Curr Opin Drug Discov Devel; 2003 May; 6(3):377-83. PubMed ID: 12833671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Z' factor including siRNA design quality parameter in RNAi screening experiments.
    Mazur S; Kozak K
    RNA Biol; 2012 May; 9(5):624-32. PubMed ID: 22614837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.